September 25, 2017 to operate medical service concerning healthcare and esthetics under trademark “Wuttisak Clinic”. 3. Analysis of Operating Results Profit & Loss Statements (MB) for the Quarter 1 Ending 31

March 2020, which net profit has changed more than 20% from the last year as follows: Statement of Comprehensive Income Unit: Million Baht 31 March 2020 31 March 2019 Increased (Decreased) Percentage

comprehensive loss for the period -25.86 -95.22 69.364 72.85 Non-controlling interests of the subsidiaries -0.01 -3.57 3.56 -99.72 Profit(Loss) attributable to equity holders of the company -25.75 -90.94 65.19

EBITDA per ton of $140 – all-time record high  Core Net Profit of $175 million - up 85% year-on-year  Core EPS of THB 0.99 – 55% increase year-on-year post 11% dilution from partial warrants exercise

lower stock loss. As aforementioned, the company realized net profit of THB 22 million, a decrease of 66% compare to 1Q2018. As of 31 March 2019, the company has total assets in the amount of THB 12,799

% 215 -32% 361 730 -51% Adjusted EBITDA Margin (%) 4.4% 6.8% -2.4% 7.6% -3.2% 5.9% 8.2% -2.3% Net Profit -36 67 -154% 20 -280% -16 131 -112% Item from raw materials derogation 14 -2,004 -101% 2 600% 16

% 63 (119) -290% Elimination (52) (3) (7) (99) (10) Profit attributable to owners of the Company 993 1,146 1,007 1% -12% 3,076 2,153 -30% Basic earnings per share (Baht) 0.72 0.83 0.73 2.23 1.56 Note: 1

ACC6207/003 25 July 2019 Subject Inform the progress of the sale stock in the subsidiary company To Director/ Managing Director The Stock Exchange of Thailand Refer to the company's letter No

expenses 9.84 132.97 11.30 23.56 Profit (Loss) before tax (197.67) (2,671.21) (19.64) (40.95) Tax - - - - Net Profit (loss) for the period (197.67) (2,671.21) (19.64) (40.95) Profit (Loss) attributable to

benefit expenses 14.16 124.10 17.84 33.51 Financial cost 0.14 1.23 0.34 0.64 Share of losses in associates 64.23 562.93 2.91 5.46 Profit (Loss) before tax (274.97) (2,409.90) (94.15) (176.84) Tax